Baxter International | BAX - L'Utile Ante Imposte

Prezzo Delle Azioni
17.07
Cambio Giornaliero
0.32 1.91%
Mensile
2.71%
Annuale
-44.43%
Q2 Previsione
16.85




L'Utile Ante Imposte Cambiamento Data
Abbott USD 2.39B 27M 2026-03
AngioDynamics USD -6.4M 5.03M 2025-09
Artivion USD 11.4M 7.84M 2025-12
AtriCure USD 394K 1.97M 2026-03
Avanos Medical USD 1.2M 2.4M 2025-12
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Dexcom USD 340.7M 40.7M 2025-12
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Fresenius EUR 601M 122M 2025-12
Globus Medical USD 143.99M 44.18M 2025-09
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
ICU Medical USD 70.3M 36.62M 2025-09
Inogen USD -6.06M 467K 2024-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD 4.31M 11.13M 2025-12
Intuitive Surgical USD 955.6M 100.4M 2025-12
J&J USD 7.82B 2.86B 2026-03
Laboratory Of America USD 8.73B 8.54B 2026-03
Masimo USD 74.9M 19.5M 2025-09
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 51.06M 22.12M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Smith & Nephew USD 469M 70M 2025-12
Stryker USD 1.7B 676M 2025-12
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Terumo JPY 45.38B 578M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12